Riyadh to host global biotech leaders for RGMBS 2026

Riyadh will host the fourth Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together more than 100 speakers and delegations from more than 70 countries. The event is designed to advance Saudi Arabia’s biotech strategy, with a focus on research, regulation, manufacturing and investment.

Why it matters: - RGMBS 2026 is meant to help Saudi Arabia build a fuller biotech ecosystem, from research and trials to manufacturing and commercialization. - The summit aligns with the Kingdom’s National Biotechnology Strategy, which aims to add $34.6 billion to non-oil GDP by 2040. - More than 65 agreements and memorandums of understanding are the target over the three-day event, signaling a push for concrete partnerships.

What happened: - The Riyadh Global Medical Biotechnology Summit will take place in Riyadh from Sept. 14-16, 2026. - The fourth edition expects more than 15,000 attendees, more than 100 local and international speakers, 200 health care and biotech brands, and more than 80 government and industry exhibitors. - Delegations from more than 70 countries are expected to attend. - Registration is open for delegates, exhibitors and partners through rgmbs.org.

The details: - The summit’s six themes are artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. - The scientific program covers the full biomedical innovation chain, including AI-driven drug discovery, genome research, local production, regulation, commercialization and investment. - Organizers say the program reflects Saudi Arabia’s effort to build an ecosystem in which each stage supports the next. - The summit will include scientific sessions, panel discussions, workshops and agreement signings. - International delegates will see the regulatory frameworks and manufacturing infrastructure Saudi Arabia is building. - The summit is held under the supervision of the Ministry of the National Guard, through Health Affairs, and hosted by KAIMRC and KSAU-HS. - The Ministry of Investment, Invest Saudi and SADAIA are strategic lead partners.

Between the lines: - The event is not positioned as a standalone conference. It is being used as a policy and business platform to attract talent, capital and global research ties. - Z.E. Prof. Bandar Alknawy said the focus this year is on “building the foundations for excellence in biotechnology,” shifting emphasis from global reach to structural depth. - Alknawy also highlighted partnerships with Harvard University, AstraZeneca and Peking University. - The emphasis on labs, integrated research centers, clinical trial networks, biomanufacturing capacity and digital platforms shows where Saudi Arabia wants to close capability gaps.

What’s next: - Organizers expect the summit to produce new deals, partnerships and investment links during the three-day program. - The event will serve as a showcase for Saudi Arabia’s regulatory and production capabilities as the Kingdom tries to position itself as a regional and global biotech hub. - Attendees can follow the summit on social media using #RGMBS2026.

The bottom line: - Riyadh is using RGMBS 2026 to turn biotech ambition into infrastructure, partnerships and policy execution.